Tag: Regulatory

OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma
Healthcare Product Reviews

OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma

April 7, 2025
admin

NEW YORK, March 11, 2025–(BUSINESS WIRE)–OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies…

Continue Reading
Products | UK Regulatory Outlook January 2024 – Osborne Clarke
Healthcare Product Reviews

Products | UK Regulatory Outlook January 2024 – Osborne Clarke

July 31, 2024
admin

General Product Safety Regulation comes into effect | Right to repair – what’s next in 2024?…

Continue Reading